Early in Alzheimer’s disease, your brain can begin to change long before anyone notices a lost name or missed appointment.

The research is in its early stages but offers “encouraging” evidence of a potential treatment for Alzheimer’s ...

A recent study led by a team of researchers at The Johns Hopkins University School of Medicine examining aging mice has provided what is believed to be the first evidence that amyloid beta ...

On July 2, the U.S. Food and Drug Administration (FDA) approved a new drug for treating Alzheimer’s disease. Donanemab, or Kisunla, is the third drug approved to target one of the causes of ...

Prof. Liu Cong from the Shanghai Institute of Organic Chemistry of the Chinese Academy of Sciences, along with collaborators, ...

Researchers have found that 40 Hz auditory stimulation may help clear the brain of amyloid plaques. Read on to ​discover more ...

A protein notorious for its role in Alzheimer’s disease may hold the key to supercharging the aging immune system, according to new research. Scientists have found that a byproduct of amyloid-beta ...

Ledvina HE, Sayegh R, Carale RO, Burroughs AM, Macklin AR, Azadeh AL, Borja Najera LD, Aravind L, Whiteley AT. Functional amyloid proteins confer defence against predatory bacteria. Nature. 2025 ...

An estimated 50 million people worldwide have dementia, with Alzheimer's disease—accounting for more than 70%—being the representative neurodegenerative brain disorder. A Korean research team has, for ...

bacteriovorus is a predatory bacterium that preys on Gram-negative bacteria. B. bacteriovorus invades the prey-cell periplasm – the space between the inner and outer membrane – leaches host nutrients ...